Constantiam Biosciences

Elucidating Genetic Variation to Power Genomic Medicine

[Constantiam Biosciences @ConstantiamBio]

Every mother hopes for a healthy baby. Every family deserves answers they can trust.

This #WorldHealthDay, we’re reminded how vital clarity is in genetic testing—especially during pregnancy and early life.

At Constantiam, we turn uncertainty into understanding.

[Constantiam Biosciences @ConstantiamBio]

Moved into BioLabs. Still unpacking VUS.

We’re excited to share that #ConstantiamBiosciences is now a proud resident at @biolabs, a space that fuels bold science, purposeful innovation, and yes, the power of RareScan’s proprietary high-throughput functional data.

[Constantiam Biosciences @ConstantiamBio]

Quarterly sync, wherever we are 🌐

From screens to the same table, our team came together for the Q2 meeting to share updates, align goals, and keep pushing the mission forward.
#Constantiambiosciences #QuarterlyMeeting #PrecisionMedicine

[Constantiam Biosciences @ConstantiamBio]

Our co-founders, Norman Ong and Daniel Goldman, are at ACMG 2025.
📍Meet us at Booth 333 to learn how Constantiam Biosciences is advancing precision medicine with cutting-edge solutions for VUS resolution, rare disease diagnosis, and functional genomics.
#ACMGMtg25 #ACMG2025

[Constantiam Biosciences @ConstantiamBio]

We’re heading to the Annual Clinical Genetics Meeting 25 in Los Angeles! Join us at Booth 333 to explore how our cutting-edge functional genomic platform is transforming precision medicine.

RareScan™ – Advancing rare disease diagnosis with deep mutational scanning.
#ACMGMtg25

[Constantiam Biosciences @ConstantiamBio]

Exciting news! We've been awarded a $2.05M Phase II SBIR grant from @NHGRI to expand our Varify™ computational engine & integrate it with MAVEvidence™, supporting clinical geneticists in improving patient care.
https://t.co/Wg6Zqs2mRt

#ConstantiamBiosciences #NHGRI #SBIRgrant

[Constantiam Biosciences @ConstantiamBio]

ASCO's new guidelines for recommending germline testing to cancer patients:
Using multigene panels for significant variants.
Testing high-risk genes by cancer type (e.g., BRCA1/2 for breast cancer).
Offering germline testing regardless of prior tests. https://t.co/rOW6IXuM8l

[Constantiam Biosciences @ConstantiamBio]

Navigate the path to clarity with MAVEvidence: Where every resolved VUS accelerates our journey towards precise, personalized genetic care.
Learn more https://t.co/gQGRn87hk1

[Constantiam Biosciences @ConstantiamBio]

Transform VUS complexity into clarity with #MAVEvidence, the premier functional evidence resource.
Dive into our vast database of over 186,000 pieces of evidence across 124,000 variants for precise, up-to-date insights.

[Constantiam Biosciences @ConstantiamBio]

Join Dr. Victoria Parikh in our upcoming webinar to explore how scalable assays are revolutionizing genetic testing in cardiac genetics. Discover the role of functional evidence in clarifying VUS and advancing precision medicine.
Register here: https://t.co/0A8Qb2qYUz

[Constantiam Biosciences @ConstantiamBio]

During #MedicalGeneticsAwarenessWeek, we celebrate our partnership with the medical community in advancing genetic research. Our platform, MAVEvidence™, embodies our shared mission with #ACMG to improve health outcomes through the power of genetic insights. #ACMGMtg24

[Constantiam Biosciences @ConstantiamBio]

Constantiam Biosciences celebrates #MedicalGeneticsAwareness Week with ACMG, honoring the heroes transforming patient care through genetics. Together, we're advancing patient care, one genetic insight at a time. #ACMGMtg24 #ACMG24

[Constantiam Biosciences @ConstantiamBio]

This #NationalHeartMonth, we highlight Dr. Victoria Parikh's insights on MAVES' vital role in cardiovascular care. Discover how genetic testing is revolutionizing the fight against heart conditions and CVDs.
#HeartHealth #GeneticTesting #MAVEvidence #ConstantiamBiosciences

[Constantiam Biosciences @ConstantiamBio]

On #RareDiseaseDay2024 , we stand with 300 million people facing rare diseases. Constantiam Biosciences' MAVEvidence offers hope through genetic insights, driving forward diagnosis & treatment. Together, let's ensure no disease is too rare to care about. #MAVEvidence

[Constantiam Biosciences @ConstantiamBio]

This #NationalHeartMonth, we highlight Dr. Victoria Parikh's insights on MAVES' vital role in cardiovascular care. Discover how genetic testing is revolutionizing the fight against heart conditions and CVDs.
#HeartHealth #GeneticTesting #MAVEvidence #ConstantiamBiosciences

[Constantiam Biosciences @ConstantiamBio]

Sometimes, even genetic variants need a little reassurance! 🧬😄 Facing an identity crisis, our VUS found comfort in the wise words of its therapist.
Let's remember that every piece of our genetic puzzle has its place and purpose.
#humor #VUS #genetics

[Constantiam Biosciences @ConstantiamBio]

Advancing BRCA1 gene research in #cervicalcancer with #MAVEvidence. Our tool provides crucial, updated genetic data, enhancing diagnosis accuracy and closing gaps in assessment.
#CervicalCancerAwarenessMonth

[Constantiam Biosciences @ConstantiamBio]

January is #CervicalCancerAwarenessMonth. At Constantiam Biosciences, we emphasize the role of genetic testing and #MAVEvidence in understanding cervical cancer risk factors. Let's commit to advancing research and innovation in the fight against this disease.

[Constantiam Biosciences @ConstantiamBio]

Behind every great vision is a team fueled by passion and insight. Here's a glimpse into a candid moment with our Co-founders and Engineering Advisor, where discussions about #ConstantiamBiosciences' future unfold. It's these thoughtful exchanges that drive our mission forward.